1
Clinical Trials associated with a1DC loaded with HIV peptide(NIAID)A Phase I Study to Evaluate the Safety, Tolerability and Immunogenicity of a Therapeutic HIV Vaccine Composed of Autologous Dendritic Cells Loaded with Autologous Inactivated Whole Virus or Conserved Peptides in ART-treated HIV-infected Adults
This study will be done in people living with HIV to see if an investigational vaccine made from a person's own white blood cells is safe and tolerated. This study will also look at the body's immune response to the vaccine and evaluate four different methods of making the vaccine to see which method may result in better immune responses.
100 Clinical Results associated with a1DC loaded with HIV peptide(NIAID)
100 Translational Medicine associated with a1DC loaded with HIV peptide(NIAID)
100 Patents (Medical) associated with a1DC loaded with HIV peptide(NIAID)
100 Deals associated with a1DC loaded with HIV peptide(NIAID)